US FDA Panel Approval Covid-19 booster Shots for People Over 65 Years

An advisory panel of the US FDA has now given the acceptance to the novel corona virus booster vaccine shot developed be Pfizer for the people, who are more than 65 yeas along with the other people, which are at the high-risk of the disease.

But on Friday, 17^th September 2021, the US FDA panel has rejected the widespread delivery of the novel corona virus booster vaccine shots to most of the people of the United States, along with delivering a surprise blow to the plant of US government for combating the highly contagious Delta corona virus variant by the roll out of the third vaccine jabs of the novel corona virus vaccine in the upcoming weeks.

The members of the panel has voted unanimously for supporting the covid-19 boosters of the vaccine to the general public of the United States, and this move of the US FDA has been made for the purpose of clearing the way for the covid-19 booster jabs only for the older and who are at-risk as Joe Biden, president of the United States has planned for hosting a novel corona virus summit on the side-lines of the United States General Assembly based in New York in the coming weeks.

The government of the United States has been pushing the partner countries for the purpose of increasing the availability of the novel corona virus vaccines across the globe, and the World Health Organization has urged the United States for holding off the provided covid-19 boosters to the citizens of the country until more population of the world has received an initial inoculation.